CN Stock MarketDetailed Quotes

301108 Tongling Jieya Biologic Technology

Watchlist
  • 26.28
  • +0.33+1.27%
Market Closed Dec 27 15:00 CST
2.13BMarket Cap37.92P/E (TTM)

Tongling Jieya Biologic Technology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-8.79%407.97M
1.99%285.07M
1.43%129.64M
-6.60%622.59M
-14.91%447.27M
-22.26%279.52M
-29.24%127.8M
-32.29%666.56M
-35.46%525.64M
-42.62%359.55M
Operating revenue
-8.79%407.97M
1.99%285.07M
1.43%129.64M
-6.60%622.59M
-14.91%447.27M
-22.26%279.52M
-29.24%127.8M
-32.29%666.56M
-35.46%525.64M
-42.62%359.55M
Other operating revenue
----
-80.55%3.57M
----
65.43%30.2M
----
18.54%18.36M
----
28.38%18.25M
----
156.21%15.49M
Total operating cost
6.06%385.58M
20.49%264.89M
32.12%124.19M
0.21%513.52M
-2.48%363.56M
-13.78%219.84M
-27.22%93.99M
-30.88%512.42M
-38.52%372.81M
-45.74%254.98M
Operating cost
7.38%328.67M
22.01%228.34M
31.10%104.56M
-4.09%438.15M
-12.80%306.09M
-22.87%187.16M
-33.97%79.75M
-30.91%456.83M
-35.86%351.03M
-42.67%242.66M
Operating tax surcharges
-25.23%3.02M
-6.24%2.35M
13.67%1.28M
35.21%6.57M
20.64%4.04M
79.79%2.51M
94.22%1.12M
-31.86%4.86M
-45.90%3.35M
-70.06%1.39M
Operating expense
-8.78%7.58M
33.96%4.98M
69.06%2.55M
34.86%9.66M
107.14%8.31M
60.06%3.71M
66.71%1.51M
2.99%7.16M
-26.59%4.01M
-35.42%2.32M
Administration expense
3.01%37.78M
14.33%25.53M
10.82%12.14M
38.08%48.56M
59.24%36.67M
72.27%22.33M
74.95%10.96M
30.31%35.17M
36.51%23.03M
8.10%12.96M
Financial expense
32.12%-6.35M
12.03%-6.28M
63.53%-1.62M
29.28%-11.94M
66.22%-9.36M
59.76%-7.14M
18.35%-4.44M
-730.32%-16.89M
-2,489.31%-27.71M
-744.88%-17.75M
-Interest expense (Financial expense)
-17.02%536.3K
-88.71%411.26K
-22.31%207.75K
-45.80%1.01M
-54.21%646.28K
283.54%3.64M
-44.19%267.39K
14.89%1.86M
24.35%1.41M
20.95%949.64K
-Interest Income (Financial expense)
17.44%-6.67M
37.24%-5.7M
26.92%-2.31M
6.45%-11.86M
53.92%-8.08M
21.78%-9.08M
43.07%-3.16M
-109.50%-12.68M
-361.78%-17.53M
-382.86%-11.61M
Research and development
-16.44%14.88M
-11.57%9.97M
3.64%5.28M
-10.96%22.52M
-6.72%17.81M
-15.83%11.27M
-15.81%5.09M
-30.48%25.29M
-35.10%19.09M
-43.43%13.39M
Credit Impairment Loss
-27.36%690.79K
-12.75%467.03K
-41.70%1.64M
239.33%1.14M
158.17%951.02K
127.40%535.28K
382.24%2.82M
-17.42%-814.6K
-706.91%-1.63M
-15.07%-1.95M
Asset Impairment Loss
-233.20%-1.73M
-283.98%-1.38M
290.86%195.17K
-158.37%-11.98M
92.73%-517.79K
89.55%-359.54K
88.35%-102.26K
-155.34%-4.64M
-202.69%-7.12M
-67.76%-3.44M
Other net revenue
-26.06%16.5M
-34.73%9.52M
1.35%9.13M
46.56%25.78M
855.56%22.31M
2,571.46%14.59M
167.51%9.01M
161.45%17.59M
-187.00%-2.95M
-140.90%-590.18K
Fair value change income
53.76%7.22M
111.05%4.2M
970.18%2.5M
795.57%9.06M
213.11%4.7M
188.68%1.99M
-82.90%233.27K
-15.57%1.01M
---4.15M
---2.24M
Invest income
-42.79%7.19M
-53.55%4.38M
-15.59%3.8M
55.44%18.52M
563.12%12.57M
1,276.78%9.43M
--4.5M
--11.92M
--1.9M
--685K
-Including: Investment income associates
---7.98M
---5.49M
---927.09K
---810.05K
----
----
----
----
----
----
Asset deal income
70.45%-29.85K
-77.37%-29.85K
-52.71%6.09K
-72.18%319.55K
-312.96%-101.01K
-124.44%-16.83K
--12.88K
295.26%1.15M
-83.68%47.43K
-70.51%68.84K
Other revenue
-33.21%3.15M
-37.30%1.89M
-35.86%994.39K
-2.74%8.72M
-41.15%4.72M
-52.19%3.01M
-32.53%1.55M
15.69%8.96M
54.50%8.01M
92.43%6.29M
Operating profit
-63.32%38.89M
-60.00%29.71M
-65.94%14.58M
-21.48%134.85M
-29.26%106.02M
-28.58%74.26M
-21.91%42.82M
-31.27%171.73M
-29.13%149.88M
-33.51%103.98M
Add:Non operating Income
246.56%1.36M
674.90%1.36M
13,888.41%1.17M
-43.16%417.93K
-37.51%391.83K
-71.30%175.08K
-95.83%8.38K
-70.81%735.25K
-38.21%627K
2.68%610K
Less:Non operating expense
234.06%731.6K
528.04%673.78K
66,115.10%616.75K
-97.48%259.95K
-90.45%219K
-95.09%107.28K
-99.83%931.44
1,931.73%10.3M
566.13%2.29M
2,630.77%2.18M
Total profit
-62.79%39.51M
-59.12%30.39M
-64.65%15.14M
-16.75%135.01M
-28.35%106.2M
-27.41%74.33M
-21.38%42.83M
-35.61%162.16M
-30.14%148.22M
-34.73%102.4M
Less:Income tax cost
-62.65%4.94M
-58.33%3.89M
-77.22%1.27M
-3.46%20.46M
-31.37%13.24M
-29.49%9.34M
-20.83%5.56M
-33.35%21.2M
-28.60%19.29M
-32.79%13.25M
Net profit
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
-27.10%64.99M
-21.47%37.26M
-35.94%140.97M
-30.37%128.93M
-35.01%89.16M
Net profit from continuing operation
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
-27.10%64.99M
-21.47%37.26M
-35.94%140.97M
-30.37%128.93M
-35.01%89.16M
Less:Minority Profit
81.26%-115.1K
16.71%-91.06K
-280.73%-29.33K
---655.9K
---614.36K
---109.33K
---7.7K
----
----
----
Net profit of parent company owners
-62.94%34.68M
-59.16%26.59M
-62.70%13.9M
-18.28%115.2M
-27.42%93.58M
-26.98%65.1M
-21.45%37.27M
-35.94%140.97M
-30.37%128.93M
-35.01%89.16M
Earning per share
Basic earning per share
-62.61%0.43
-58.75%0.33
-63.04%0.17
-18.39%1.42
-27.67%1.15
-27.27%0.8
-20.69%0.46
-50.57%1.74
-47.70%1.59
-51.11%1.1
Diluted earning per share
-62.61%0.43
-58.75%0.33
-63.04%0.17
-18.39%1.42
-27.67%1.15
-27.27%0.8
-20.69%0.46
-50.57%1.74
-47.70%1.59
-51.11%1.1
Other composite income
Total composite income
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
-27.10%64.99M
-21.47%37.26M
-35.94%140.97M
-30.37%128.93M
-35.01%89.16M
Total composite income of parent company owners
-62.94%34.68M
-59.16%26.59M
-62.70%13.9M
-18.28%115.2M
-27.42%93.58M
-26.98%65.1M
-21.45%37.27M
-35.94%140.97M
-30.37%128.93M
-35.01%89.16M
Total composite income of minority owners
81.26%-115.1K
16.71%-91.06K
-280.73%-29.33K
---655.9K
---614.36K
---109.33K
---7.7K
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -8.79%407.97M1.99%285.07M1.43%129.64M-6.60%622.59M-14.91%447.27M-22.26%279.52M-29.24%127.8M-32.29%666.56M-35.46%525.64M-42.62%359.55M
Operating revenue -8.79%407.97M1.99%285.07M1.43%129.64M-6.60%622.59M-14.91%447.27M-22.26%279.52M-29.24%127.8M-32.29%666.56M-35.46%525.64M-42.62%359.55M
Other operating revenue -----80.55%3.57M----65.43%30.2M----18.54%18.36M----28.38%18.25M----156.21%15.49M
Total operating cost 6.06%385.58M20.49%264.89M32.12%124.19M0.21%513.52M-2.48%363.56M-13.78%219.84M-27.22%93.99M-30.88%512.42M-38.52%372.81M-45.74%254.98M
Operating cost 7.38%328.67M22.01%228.34M31.10%104.56M-4.09%438.15M-12.80%306.09M-22.87%187.16M-33.97%79.75M-30.91%456.83M-35.86%351.03M-42.67%242.66M
Operating tax surcharges -25.23%3.02M-6.24%2.35M13.67%1.28M35.21%6.57M20.64%4.04M79.79%2.51M94.22%1.12M-31.86%4.86M-45.90%3.35M-70.06%1.39M
Operating expense -8.78%7.58M33.96%4.98M69.06%2.55M34.86%9.66M107.14%8.31M60.06%3.71M66.71%1.51M2.99%7.16M-26.59%4.01M-35.42%2.32M
Administration expense 3.01%37.78M14.33%25.53M10.82%12.14M38.08%48.56M59.24%36.67M72.27%22.33M74.95%10.96M30.31%35.17M36.51%23.03M8.10%12.96M
Financial expense 32.12%-6.35M12.03%-6.28M63.53%-1.62M29.28%-11.94M66.22%-9.36M59.76%-7.14M18.35%-4.44M-730.32%-16.89M-2,489.31%-27.71M-744.88%-17.75M
-Interest expense (Financial expense) -17.02%536.3K-88.71%411.26K-22.31%207.75K-45.80%1.01M-54.21%646.28K283.54%3.64M-44.19%267.39K14.89%1.86M24.35%1.41M20.95%949.64K
-Interest Income (Financial expense) 17.44%-6.67M37.24%-5.7M26.92%-2.31M6.45%-11.86M53.92%-8.08M21.78%-9.08M43.07%-3.16M-109.50%-12.68M-361.78%-17.53M-382.86%-11.61M
Research and development -16.44%14.88M-11.57%9.97M3.64%5.28M-10.96%22.52M-6.72%17.81M-15.83%11.27M-15.81%5.09M-30.48%25.29M-35.10%19.09M-43.43%13.39M
Credit Impairment Loss -27.36%690.79K-12.75%467.03K-41.70%1.64M239.33%1.14M158.17%951.02K127.40%535.28K382.24%2.82M-17.42%-814.6K-706.91%-1.63M-15.07%-1.95M
Asset Impairment Loss -233.20%-1.73M-283.98%-1.38M290.86%195.17K-158.37%-11.98M92.73%-517.79K89.55%-359.54K88.35%-102.26K-155.34%-4.64M-202.69%-7.12M-67.76%-3.44M
Other net revenue -26.06%16.5M-34.73%9.52M1.35%9.13M46.56%25.78M855.56%22.31M2,571.46%14.59M167.51%9.01M161.45%17.59M-187.00%-2.95M-140.90%-590.18K
Fair value change income 53.76%7.22M111.05%4.2M970.18%2.5M795.57%9.06M213.11%4.7M188.68%1.99M-82.90%233.27K-15.57%1.01M---4.15M---2.24M
Invest income -42.79%7.19M-53.55%4.38M-15.59%3.8M55.44%18.52M563.12%12.57M1,276.78%9.43M--4.5M--11.92M--1.9M--685K
-Including: Investment income associates ---7.98M---5.49M---927.09K---810.05K------------------------
Asset deal income 70.45%-29.85K-77.37%-29.85K-52.71%6.09K-72.18%319.55K-312.96%-101.01K-124.44%-16.83K--12.88K295.26%1.15M-83.68%47.43K-70.51%68.84K
Other revenue -33.21%3.15M-37.30%1.89M-35.86%994.39K-2.74%8.72M-41.15%4.72M-52.19%3.01M-32.53%1.55M15.69%8.96M54.50%8.01M92.43%6.29M
Operating profit -63.32%38.89M-60.00%29.71M-65.94%14.58M-21.48%134.85M-29.26%106.02M-28.58%74.26M-21.91%42.82M-31.27%171.73M-29.13%149.88M-33.51%103.98M
Add:Non operating Income 246.56%1.36M674.90%1.36M13,888.41%1.17M-43.16%417.93K-37.51%391.83K-71.30%175.08K-95.83%8.38K-70.81%735.25K-38.21%627K2.68%610K
Less:Non operating expense 234.06%731.6K528.04%673.78K66,115.10%616.75K-97.48%259.95K-90.45%219K-95.09%107.28K-99.83%931.441,931.73%10.3M566.13%2.29M2,630.77%2.18M
Total profit -62.79%39.51M-59.12%30.39M-64.65%15.14M-16.75%135.01M-28.35%106.2M-27.41%74.33M-21.38%42.83M-35.61%162.16M-30.14%148.22M-34.73%102.4M
Less:Income tax cost -62.65%4.94M-58.33%3.89M-77.22%1.27M-3.46%20.46M-31.37%13.24M-29.49%9.34M-20.83%5.56M-33.35%21.2M-28.60%19.29M-32.79%13.25M
Net profit -62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M-27.10%64.99M-21.47%37.26M-35.94%140.97M-30.37%128.93M-35.01%89.16M
Net profit from continuing operation -62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M-27.10%64.99M-21.47%37.26M-35.94%140.97M-30.37%128.93M-35.01%89.16M
Less:Minority Profit 81.26%-115.1K16.71%-91.06K-280.73%-29.33K---655.9K---614.36K---109.33K---7.7K------------
Net profit of parent company owners -62.94%34.68M-59.16%26.59M-62.70%13.9M-18.28%115.2M-27.42%93.58M-26.98%65.1M-21.45%37.27M-35.94%140.97M-30.37%128.93M-35.01%89.16M
Earning per share
Basic earning per share -62.61%0.43-58.75%0.33-63.04%0.17-18.39%1.42-27.67%1.15-27.27%0.8-20.69%0.46-50.57%1.74-47.70%1.59-51.11%1.1
Diluted earning per share -62.61%0.43-58.75%0.33-63.04%0.17-18.39%1.42-27.67%1.15-27.27%0.8-20.69%0.46-50.57%1.74-47.70%1.59-51.11%1.1
Other composite income
Total composite income -62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M-27.10%64.99M-21.47%37.26M-35.94%140.97M-30.37%128.93M-35.01%89.16M
Total composite income of parent company owners -62.94%34.68M-59.16%26.59M-62.70%13.9M-18.28%115.2M-27.42%93.58M-26.98%65.1M-21.45%37.27M-35.94%140.97M-30.37%128.93M-35.01%89.16M
Total composite income of minority owners 81.26%-115.1K16.71%-91.06K-280.73%-29.33K---655.9K---614.36K---109.33K---7.7K------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.